Publications

Preclinical rationale for combining the Smac-mimetic Debio 1143 with concurrent chemioradiotherapy in LA-SCCHN

A Phase I-II evaluation of the safety and efficacy of the oral HSP90 inhibitor Debio 0932 in combination with Standard…

The cyclophilin inhibitor alisporivir prevents hepatitis C virus–mediated mitochondrial dysfunction

Debio-025 is more effective than prednisone in reducing muscular pathology in mdx mice

HCV resistance to cyclosporin A does not correlate with a resistance of the NS5A-cyclophilin A interaction to cyclophilin inhibitors.

Human liver chimeric mice provide a model for hepatitis B and C virus infection and treatment

Triptorelin 6-Month Formulation in the Management of Patients with Locally Advanced and Metastatic Prostate Cancer

Debio-025 inhibits HIV-1 by interfering with an early event in the replication cycle

Cyclosporine A inhibits hepatitis C virus nonstructural protein 2 through cyclophilin A.